Kathryn Lindsay Pollock

Title: Kathryn Lindsay Pollock: Innovator in Cell Therapy

Introduction

Kathryn Lindsay Pollock is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of cell therapy, holding a total of 5 patents. Her work focuses on improving the safety and efficacy of therapeutic T cell compositions.

Latest Patents

One of her latest patents is titled "Determining toxicity risk in CAR T-cell therapy." This patent provides methods, compositions, and articles of manufacture for use in cell therapy involving the administration of therapeutic T cell compositions. The T cell composition includes cells that express recombinant receptors, such as chimeric antigen receptors (CARs). The features of this invention offer various advantages, including a lower risk of toxicity in subjects receiving the T cell compositions. Another notable patent is related to "Cryopreservative compositions and methods." This disclosure describes a cryopreservative composition that includes a sugar component and a sugar alcohol component, which is effective for storing and recovering cells without the need for dimethyl sulfoxide (DMSO).

Career Highlights

Kathryn has worked with esteemed organizations such as the University of Minnesota and Juno Therapeutics. Her experience in these institutions has allowed her to advance her research and contribute to the development of innovative therapies.

Collaborations

She has collaborated with notable colleagues, including Allison Hubel and Brian Christin, further enhancing her work in the field of cell therapy.

Conclusion

Kathryn Lindsay Pollock is a trailblazer in the realm of cell therapy, with her patents reflecting her commitment to improving patient outcomes. Her innovative approaches continue to shape the future of therapeutic treatments.